BioSpace News Archive

CinCor Pharma, Inc. (“CinCor”) announced today the topline results and successful completion of its Phase 2 BrigHtn trial evaluating the efficacy and safety of baxdrostat.

Compugen Ltd. announced today that the European Patent Office has granted Compugen a new patent covering anti-PVRIG antibodies for use in cancer treatment.

TAGRISSO® plus savolitinib demonstrated 49% objective response rate in lung cancer patients with high levels of MET overexpression and/or amplification in SAVANNAH Phase II trial.

Viatris Inc. (NASDAQ: VTRS) today reported strong results for the second quarter of 2022 and provided an update to its full year 2022 financial guidance.

Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company developing ARCUS®-based ex vivo allogeneic CAR T and in vivo gene editing therapies, today announced financial results for the second quarter ended June 30, 2022 and provided a business update.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today reported financial results for the three months ended June 30, 2022, and highlighted recent progress.

Hyperlipidemia is a technical term for abnormal amounts of fats in the blood. The two noteworthy sorts of lipids found in the blood are triglycerides and cholesterol.

According to Transparency Market Research’s latest report on the global dental practice management software market for the historical period 2017-2018 and forecast period 2019-2027, value added features in dental practice management software, software integration and increase in dental visits are projected to drive the global dental practice management software market during the forecast period.

Cardiac arrhythmia relates to irregular rate or rhythm of heartbeat, and while most of these conditions are fairly harmless, certain cases can be utterly serious and even lead to death as the lack of blood flow can severely damage the heart, brain, and other organs.

The global biologics safety testing market is foreseen to increase growth on the back of the rising number of drug launches and research and development investment in the life sciences industry.